Success Metrics

Clinical Success Rate
91.2%

Based on 31 completed trials

Completion Rate
91%(31/34)
Active Trials
1(2%)
Results Posted
42%(13 trials)
Terminated
3(7%)

Phase Distribution

Ph not_applicable
5
11%
Ph phase_4
13
30%
Ph phase_2
6
14%
Ph phase_1
8
18%
Ph phase_3
10
23%

Phase Distribution

8

Early Stage

6

Mid Stage

23

Late Stage

Phase Distribution42 total trials
Phase 1Safety & dosage
8(19.0%)
Phase 2Efficacy & side effects
6(14.3%)
Phase 3Large-scale testing
10(23.8%)
Phase 4Post-market surveillance
13(31.0%)
N/ANon-phased studies
5(11.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.2%

31 of 34 finished

Non-Completion Rate

8.8%

3 ended early

Currently Active

1

trials recruiting

Total Trials

44

all time

Status Distribution
Active(2)
Completed(31)
Terminated(3)
Other(8)

Detailed Status

Completed31
unknown8
Terminated3
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
44
Active
1
Success Rate
91.2%
Most Advanced
Phase 4

Trials by Phase

Phase 18 (19.0%)
Phase 26 (14.3%)
Phase 310 (23.8%)
Phase 413 (31.0%)
N/A5 (11.9%)

Trials by Status

terminated37%
active_not_recruiting12%
not_yet_recruiting12%
completed3170%
unknown818%

Recent Activity

1 active trials
Showing 5 of 44
terminatedphase_3

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

NCT06397768
completedphase_3

Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts

NCT02750202
active_not_recruitingphase_2

A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

NCT07069569
not_yet_recruitingphase_3

Optimal Timing of Hepatitis B Vaccination After Transplants

NCT06888479
completedphase_1

Study of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese Children

NCT02839161
View all 44 trials

Clinical Trials (44)

Showing 20 of 44 trialsScroll for more
NCT06397768Phase 3

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Terminated
NCT02750202Phase 3

Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts

Completed
NCT07069569Phase 2

A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

Active Not Recruiting
NCT06888479Phase 3

Optimal Timing of Hepatitis B Vaccination After Transplants

Not Yet Recruiting
NCT02839161Phase 1

Study of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese Children

Completed
NCT03537508Phase 3

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Completed
NCT03691610Phase 3

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Completed
NCT01311674Phase 3

Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)

Terminated
NCT03673462Phase 3

Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Completed
NCT03630705Phase 3

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico

Completed
NCT01049035Phase 2

A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers

Completed
NCT00257127Not Applicable

Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs

Completed
NCT01821547Phase 4

New Methods to Measure the Immune Response to Hepatitis B Vaccine

Completed
NCT03083158Phase 4

Immunity to Hepatitis B Vaccine

Completed
NCT04442841Phase 2

HBV Vaccine in Anti-core Positive Donors After LT

Unknown
NCT01014845Phase 3

Clinical Trial of Recombinant Hepatitis E Vaccine

Completed
NCT03056924

Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab

Completed
NCT02203357Phase 4

A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults

Completed
NCT02109354Phase 1

Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults

Completed
NCT02316444Phase 4

Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda

Completed

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
44